ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2016 American Transplant Congress » Concurrent Session: Identifying Antibodies - Tools of the Trade

Date: Monday, June 13, 2016

Time: 2:30pm-4:00pm

Location: Ballroom B

Session Type: Concurrent Session

Meeting: 2016 American Transplant Congress

2:30pm-2:42pm
Relationship Between Mean Fluorescence Intensity and C1q/C3d-Fixing Capacities of Anti-HLA Antibodies.

G. Claisse,1 L. Absi,2 E. Alamartine,1 N. Maillard,1 C. Mariat.1

2:42pm-2:54pm
Fc Receptor Binding Assay for Functional Assessment of HLA Antibodies: Initial Clinical Validation.

E. Woodle, A. Girnita.

2:54pm-3:06pm
Blindspots in HLA Antibody Testing: Recognition Is First Step to Nirvana.

A. Kher, P. Dorwal, V. Kher.

3:06pm-3:18pm
An Improved Method for the Evaluation of Microvascular Inflammation in Renal Allograft Biopsies.

M. Rooney,1 Z. Ping,2 D. Samarapungavan,3 R. Hennigar.4

3:18pm-3:30pm
Blocking Fc Receptor in Flow Cytometric Crossmatch: Refining an Old Assay to Improve Patient Management.

N. Brown, J. Wang, S. Marino.

3:30pm-3:42pm
Effect of Complement Inhibition Therapy (Eculizumab) in Patients with C1q-Binding Donor-Specific Anti-HLA Antibodies: A Molecular Appraisal.

C. Lefaucheur,1 L. Hidalgo,2 J. Reeve,2 D. Viglietti,1 C. Gosset,1 O. Aubert,3 C. Ulloa,3 C. Legendre,3 D. Glotz,1 P. Halloran,2 A. Loupy.3

3:42pm-3:54pm
Composite Score to Define the Risk of Allograft Loss After Standard-of-Care Treatment of Antibody-Mediated Rejection in Kidney Transplantation.

D. Viglietti,1 A. Loupy,2 J. Duong Van Huyen,2 J. Verine,1 A. Zeevi,3 C. Legendre,2 D. Glotz,1 C. Lefaucheur.1

« View all sessions from the 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences